Nexzone S 250mg/125mg Injection
Marketer
Gurnex Biotech
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Nexzone S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administer this medication strictly under a healthcare provider's guidance. Complete the prescribed dosage, even with symptom improvement; premature cessation may compromise its efficacy. Regularly scheduled injections are crucial. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe reactions necessitate immediate medical attention. Report any allergic symptoms (rash, itching, edema, respiratory distress) immediately. Inform your doctor about all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals require physician consultation before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, refrain from driving if experiencing somnolence or dizziness. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your physician may order lab tests to monitor therapeutic response.
Uses of Nexzone S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Nexzone S 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Nexzone S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Nexzone S 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Nexzone S 250mg/125mg Injection works:
Ceftriaxone and Sulbactam, combined as Nexzone S 250mg/125mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone's antibiotic properties disrupt bacterial cell wall synthesis, hindering their ability to survive. Sulbactam, a beta-lactamase inhibitor, complements this by counteracting bacterial resistance mechanisms, thus optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of Nexzone S 250mg/125mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Nexzone S (250mg/125mg) is typically deemed safe for use during pregnancy. Preclinical trials using animals revealed minimal or no negative impacts on fetal development; nonetheless, clinical data from human trials are scarce.
Breast feedingCAUTION
Administering Nexzone S 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Nexzone S 250mg/125mg Injection can potentially reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if any of these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Nexzone S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
The injectable medication, Nexzone S 250mg/125mg, requires careful administration in individuals with severe hepatic impairment, potentially necessitating dosage modification. Consult a physician for guidance. Dosage alterations for Nexzone S 250mg/125mg Injection are generally unnecessary for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Nexzone S 250mg/125mg Injection :
Omit a Nexzone S 250mg/125mg Injection dose? Seek medical advice immediately.
Facts to Know About Nexzone S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently